FDA begins push to study psychedelics for mental health disorders

Donald Trump

April 24 (UPI) -- The Food and Drug Administration announced regulatory actions Friday to support development of serotonin-2A agonists and related products, including psychedelic drugs. On Saturday, President Donald Trump signed an executive order to speed up research on psychedelic drugs for mental health disorders. "Today's order will ensure that people suffering from debilitating symptoms might finally have a chance to reclaim their lives and lead a happier life," Trump said during the

Tag-uri: Donald Trump

din zilele anterioare